Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss

Obesity Treatments

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

Early prescription data show strong uptake driven by a needle‑free option with efficacy comparable to injections.

Weight Returns Quickly After Stopping GLP-1 Drugs, Oxford Review Finds

Novo Nordisk Launches Wegovy Weight‑Loss Pill in U.S. at $149 Starter Price

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

Novo Nordisk Launches Wegovy Weight-Loss Drug in India